Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1825 of 2228 entries
View as:

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03993132 Org: User:
Start: 10/01/18 End: 06/16/22 Due: 06/16/23

Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02191813 Org: User:
Start: 03/31/00 End: - Due: -

Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02259855 Org: User:
Start: 01/01/06 End: - Due: -

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00274508 Org: User:
Start: 10/10/00 End: - Due: -

Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00612885 Org: User:
Start: 03/31/04 End: 08/31/05 Due: 08/31/06

Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253953 Org: User:
Start: 11/30/02 End: - Due: -

Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

Phase: N/A Priority: Normal
NCT ID: NCT00615108 Org: User:
Start: 12/31/06 End: - Due: -

A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02632721 Org: User:
Start: 06/16/16 End: 01/16/23 Due: 01/16/24

A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT05658107 Org: User:
Start: 01/16/23 End: 03/19/24 Due: 03/19/25

Safety and Tolerability of Dabigatran Etexilate in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00844415 Org: User:
Start: 06/01/09 End: - Due: -

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02256748 Org: User:
Start: 06/30/05 End: - Due: -

A Study in Healthy Men to Test How BI 1810631 is Taken up in the Body When Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT06075277 Org: User:
Start: 10/19/23 End: 01/02/24 Due: 01/02/25

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT04876391 Org: User:
Start: 08/24/21 End: 04/26/24 Due: 04/26/25

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01528735 Org: User:
Start: 02/29/12 End: 08/31/13 Due: 08/31/14

Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00737100 Org: User:
Start: 09/30/08 End: - Due: -

Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02254005 Org: User:
Start: 10/01/02 End: - Due: -

The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264145 Org: User:
Start: 11/30/98 End: - Due: -

Drug Utilization Study for Olodaterol

Phase: N/A Priority: Normal
NCT ID: NCT03030638 Org: User:
Start: 02/08/17 End: 03/31/18 Due: 03/31/19

Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01983566 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

Phase: N/A Priority: Normal
NCT ID: NCT00659581 Org: User:
Start: 04/30/06 End: - Due: -

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02864914 Org: User:
Start: 03/15/16 End: 07/29/22 Due: 07/29/23

SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Phase: N/A Priority: Normal
NCT ID: NCT01774370 Org: User:
Start: 01/14/13 End: 02/17/17 Due: 02/17/18

Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02273453 Org: User:
Start: 02/28/03 End: - Due: -

A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04097223 Org: User:
Start: 11/20/19 End: 07/01/20 Due: 07/01/21

Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

Phase: N/A Priority: Normal
NCT ID: NCT02182700 Org: User:
Start: 07/31/98 End: - Due: -